1. Ferlay, J., Shin, H.R., Bray, F., Forman, D., Mathers, C. and Parkin, D.M (2010). GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No.10 [Internet]. Lyon, France: International Agency for Research on Cancer.
http://globocan.iarc.fr
(2 December 2011, date last accessed).
2. Sun, X. D., Mu, R., Zhou, Y., Dai, X., Qiao, Y., Zhang, S., et al. (2002). 1990–1992 mortality of stomach cancer in China. Chinese Journal of Oncology,
24, 4–8.
3. Labialle, S., Gayet, L., Marthinet, E., Rigal, D., & Baggetto, L. G. (2002). Transcriptional regulators of the human multidrug resistance 1 gene: recent views. Biochemical Pharmacology,
64, 943–948.
4. Steinbach, D., & Legrand, O. (2007). ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra? Leukemia,
21, 1172–1176.
5. Mignogna, C., Staibano, S., Altieri, V., De Rosa, G., Pannone, G., Santoro, A., et al. (2006). Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: A 5 year follow-up analysis. BMC Cancer,
6, 293.